Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering
Posted On Tuesday, July 15, 2025
Evestia Clinical to merge with Atlantic Research Group
Posted On Tuesday, July 15, 2025
Myriad Genetics Earns 2025 Great Place To Work Certification™
Posted On Tuesday, July 15, 2025
Intelligent Bio Solutions Adds Next-Gen Wearable for Extended Drug Detection to Product Offering, Strengthening Leadership in Non-Invasive Testing
Posted On Tuesday, July 15, 2025
IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan
Posted On Tuesday, July 15, 2025
Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
Posted On Tuesday, July 15, 2025
Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide
Posted On Tuesday, July 15, 2025
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
Posted On Tuesday, July 15, 2025
OncoC4 to Present at the 2025 Orphan Drug Summit on Strategies to Eliminate Anti-Drug Antibodies in Orphan Therapies
Posted On Tuesday, July 15, 2025
Draig Therapeutics Appoints Experienced Biotech Leader Douglas E. Williams, Ph.D. as Chair of its Board of Directors
Posted On Tuesday, July 15, 2025
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
Posted On Monday, July 14, 2025
Kane Biotech to Present at Advanced Wound Care Summit USA
Posted On Monday, July 14, 2025
Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary
Posted On Monday, July 14, 2025
Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program
Posted On Monday, July 14, 2025
New 3-Year Phase 3 Data Confirmed Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism, Including Improvements in Biochemistries, Kidney Function, and Quality of Life
Posted On Monday, July 14, 2025
60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025
Posted On Monday, July 14, 2025
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
Posted On Monday, July 14, 2025
Tevogen.AI Builds Alpha Version of PredicTcell™ Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs
Posted On Monday, July 14, 2025
Borvo EVAC™ System Demonstrates 100% Success Rate in Chronic Subdural Hematoma Clinical Cases Validated Across 5 Medical Centers
Posted On Monday, July 14, 2025
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
Posted On Monday, July 14, 2025
Pineapple, Inc. to Launch Real-World Asset Token Designed to Monetize Intellectual Property
Posted On Monday, July 14, 2025
Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq’s Stockholders’ Equity Standard
Posted On Monday, July 14, 2025
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
Posted On Monday, July 14, 2025
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™
Posted On Monday, July 14, 2025
Disc Medicine Appoints Nadim Ahmed to its Board of Directors
Posted On Monday, July 14, 2025

Print